Form 4: Charles Schwab Director Joan Dea Receives Stock and Option Grants

Director Joan Dea receives stock and option grants under Charles Schwab's 2022 Stock Incentive Plan.

Summary

• Joan Dea, a director of Charles Schwab Corp, reported a transaction on May 28, 2024, involving the grant of restricted stock units and nonqualified stock options.
• Dea received 1,809 restricted stock units, which vest 25% on the first and second anniversary of the grant date and 50% on the third anniversary.
• She also received options to purchase 4,496 shares of common stock at an exercise price of $70.79, vesting on the same schedule as the restricted stock units.
• Following the reported transaction, Dea directly owns 26,724 shares of Charles Schwab common stock and options to purchase 4,496 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices. The grants align the director's interests with shareholders.

Positives

• The grant of restricted stock units and stock options aligns Dea's interests with those of the company and its shareholders.
• The vesting schedule encourages long-term commitment and performance.

Industry Context

Stock grants and options are common forms of executive compensation in the financial services industry, aligning management's interests with shareholder value.

Comparison to Industry Standards

• Companies like Goldman Sachs, Morgan Stanley, and JP Morgan Chase also utilize stock options and restricted stock units as part of their executive compensation packages.
• The vesting schedules are fairly standard across the industry, typically ranging from three to five years.

Stakeholder Impact

• The stock and option grants could positively impact shareholders by incentivizing the director to improve company performance.
• Employees may view the grants as a positive sign of the company's commitment to its leadership.

Key Dates